Italian Network for Tumor Biotherapy Foundation
4 clinical trials · Sponsor
◉ Watch Italian Network for Tumor Biotherapy Foundation
| Record | Firm | Date |
|---|---|---|
| A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 (NCT04250246) | Italian Network for Tumor Biotherapy Foundation | 2020-03-01 |
Track Italian Network for Tumor Biotherapy Foundation automatically
Every clearance here is in the API, with alerts when new ones post.